Fuller & Thaler Asset Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$366M Buy
8,542,236
+581,340
+7% +$25M 1.23% 6
2025
Q4
$349M Sell
7,960,896
-359,898
-4% -$14.9M 1.18% 7
2025
Q3
$344M Sell
8,320,794
-454,778
-5% -$18.3M 1.17% 10
2025
Q2
$387M Buy
8,775,572
+980,498
+13% +$39.2M 1.41% 4
2025
Q1
$288M Buy
7,795,074
+164,134
+2% +$5.85M 1.12% 9
2024
Q4
$254M Buy
7,630,940
+708,312
+10% +$23M 0.96% 15
2024
Q3
$180M Buy
6,922,628
+4,700,717
+212% +$117M 0.71% 37
2024
Q2
$49.9M Sell
2,221,911
-436,436
-16% -$9.68M 0.21% 148
2024
Q1
$63.1M Buy
2,658,347
+43,047
+2% +$957K 0.28% 121
2023
Q4
$62.7M Buy
2,615,300
+53,813
+2% +$1.17M 0.32% 113
2023
Q3
$56M Sell
2,561,487
-12,543
-0.5% -$262K 0.32% 105
2023
Q2
$49.2M Buy
2,574,030
+52,894
+2% +$1.02M 0.28% 116
2023
Q1
$48.9M Buy
2,521,136
+51,637
+2% +$900K 0.28% 119
2022
Q4
$39.6M Sell
2,469,499
-46,586
-2% -$760K 0.25% 131
2022
Q3
$39.5M Sell
2,516,085
-131,800
-5% -$2.55M 0.28% 117
2022
Q2
$55.1M Sell
2,647,885
-34,198
-1% -$705K 0.38% 95
2022
Q1
$60.8M Sell
2,682,083
-211,675
-7% -$4.13M 0.36% 98
2021
Q4
$52.9M Buy
2,893,758
+161,693
+6% +$3.09M 0.31% 107
2021
Q3
$57.8M Buy
2,732,065
+2,543,798
+1,351% +$47.2M 0.37% 90
2021
Q2
$3.43M Sell
188,267
-52,664
-22% -$1.23M 0.02% 284
2021
Q1
$5.44M Buy
240,931
+44,596
+23% +$1.01M 0.04% 262
2020
Q4
$3.94M Buy
196,335
+15,248
+8% +$319K 0.04% 258
2020
Q3
$4.43M Buy
181,087
+11,992
+7% +$280K 0.06% 232
2020
Q2
$4.01M Buy
169,095
+124,503
+279% +$2.89M 0.05% 233
2020
Q1
$768K Sell
44,592
-23,538
-35% -$431K 0.01% 320
2019
Q4
$1.2M Sell
68,130
-25,485
-27% -$432K 0.01% 324
2019
Q3
$1.66M Buy
+93,615
New +$1.89M 0.02% 305
2018
Q1
Sell
-3,100
Closed -$94K 783
2017
Q4
$94K Hold
3,100
﹤0.01% 529
2017
Q3
$75K Buy
+3,100
New +$82.5K ﹤0.01% 515

Other funds holding EXEL

Fuller & Thaler Asset Management's EXEL Position: Q1 2026 in Review

Fuller & Thaler Asset Management increased its Exelixis (EXEL) stake by 7.3% in Q1 2026, buying an estimated $25M and bringing the position to 8,542,236 shares worth $366M. The position accounts for 1.23% of the portfolio, ranked #6.

Fuller & Thaler Asset Management first reported a position in EXEL in Q3 2017 and has held it in 29 quarters since. The position peaked at $387M in Q2 2025. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Fuller & Thaler Asset Management held 8,542,236 shares of Exelixis worth $366M as of Q1 2026.
  • Fuller & Thaler Asset Management bought 581,340 Exelixis shares in Q1 2026, an estimated $25M.
  • Exelixis made up 1.23% of Fuller & Thaler Asset Management's portfolio in Q1 2026, its #6 holding.
  • Fuller & Thaler Asset Management first reported a position in Exelixis in Q3 2017 and has held it in 29 quarters since.
  • Fuller & Thaler Asset Management's Exelixis position peaked at $387M in Q2 2025.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2026, filed 14 May 2026.